IBRX•benzinga•
ImmunityBio Announced Registered Direct Offering Of Approximately $75M In Gross Proceeds With A Single Institutional Investor, If Fully Exercised, The Warrants Could Result In Additional Gross Proceeds Of Up To Approximately $90M
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 8, 2025 by benzinga